Abstract:Background: Breast cancer is the leading cause of cancer death in women. The current methods of chemotherapy for breast cancer generally have strong adverse reactions and drug resistance. Therefore, the discovery of novel anti-breast cancer lead compounds is urgently needed. Objective: This study aimed to design and synthesize a series of 2-alkyl substituted fluorinated genistein analogues and evaluate their anti-breast cancer activity. Methods: Target compounds were obtained in a multistep reaction synthesis. The anti-tumor activity of compounds I-1~I-35 was evaluated with MCF-7, MDA-MB-231, MDA-MB-435, and MCF-10A cell lines in vitro, with tamoxifen as the positive control. Molecular docking was used to study the interaction between the synthesized compounds and PI3K-gamma. Results: A series of 2-alkyl substituted fluorinated genistein analogues was designed, synthesized, and screened for their bioactivity. Most of the compounds displayed better selectivity toward breast cancer cell lines as compared to tamoxifen. Among these analogues, I-2, I-3, I-4, I-9, I-15, and I-17 have the strongest selective inhibition of breast cancer cells. Compounds I-10, I-13, I-15, I-17, and I- 33 were found to have significant inhibitory effects on breast cancer cells. Molecular docking studies have shown that these compounds may act as PI3Kγ inhibitors and may further exhibit anti-breast cancer effects. Conclusion: Most of the newly synthesized compounds could highly, selectively inhibit breast cancer cell lines. The experimental results indicate that the synthesized analogs may also have obvious selective inhibitory effects on other malignant proliferation cancer cells.

Synthesis and cytotoxicity of 2,3-enopyranosyl C-linked conjugates of genistein

Synthesis And Cytotoxic Evaluation Of A Series Of Genistein Derivatives

Synthesis and Cytotoxic Evaluation of Novel 7‐o‐modified Genistein Derivatives

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Biosynthesis and Anticancer Activity of Genistein Glycoside Derivatives

Synthesis and Biological Evaluation of a Natural Ester Sintenin and Its Synthetic Analogues

Synthesis and Bio-evaluation of 2-Alkyl Substituted Fluorinated Genistein Analogues Against Breast Cancer.

Synthesis and Cytotoxicity Evaluation of 3-Amino-2-hydroxypropoxygenistein Derivatives.

Synthesis And Anticancer Activity Of Glucosylated Podophyllotoxin Derivatives Linked Via 4 Beta-Triazole Rings

Glycosylation of Ent-Kaurene Derivatives and an Evaluation of Their Cytotoxic Activities.

The Mechanisms Of Anticancer Agents By Genistein And Synthetic Derivatives Of Isoflavone

Genistein and Its Synthetic Analogs As Anticancer Agents

Design and Synthesis of the Novel Oleanolic Acid-Cinnamic Acid Ester Derivatives and Glycyrrhetinic Acid-Cinnamic Acid Ester Derivatives with Cytotoxic Properties

Synthesis and in Vitro Anti-tumor Evaluation of Novel Glycoconjugated SN38 Derivatives

Synthesis and Characterization of a Series of Genistein Derivatives As Selective Estrogen Receptor Modulators

Synthesis, characterization and biological evaluation of some 16E-arylidene androstane derivatives as potential anticancer agents.

Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Synthesis of Caffeic Acid Phenethyl Ester Analogues and Their Cytotoxicities Against Human Cancer Cells

Synthesis and Cytostatic Activity of (E)-Ethyl-2-Amino-5-(3,3-Dimethyl-4-Oxobutyliden)-4-Oxo-1- (2-Phenylaminobenzamido)-4,5-Dihydro-1Hpyrrol-3-Carboxylate

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents

Synthesis and Cytotoxic Activities of Beta-Carboline Amino Acid Ester Conjugates